Drug · DIN 02230455
RISPERDAL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 5, 2009; first marketed May 28, 1999.
- Drug Identification Number (DIN)
- 02230455
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 17, 1998: NOC 3147New Drug Submission (NDS)
- January 8, 1997: NOC 4049Supplement to a New Drug Submission (SNDS) · New strength
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “risperdal”. A notice may cover another product or only some lots: read it to see what it covers.
Other DINs named RISPERDAL
- DIN 02025280 · Cancelled Post Market
- DIN 02025299 · Cancelled Post Market
- DIN 02025302 · Cancelled Post Market
- DIN 02025310 · Cancelled Post Market
- DIN 02240551 · Cancelled Post Market
- DIN 02240552 · Cancelled Post Market